| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/30/1999 | US5889160 Human IL-2 receptor γ-chain molecule antibody |
| 03/30/1999 | US5889158 Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens |
| 03/30/1999 | US5889157 Humanized B3 antibody fragments, fusion proteins, and uses thereof |
| 03/30/1999 | US5889156 TNF deletion muteins |
| 03/30/1999 | US5889155 Carbohydrate-directed cross-linking reagents |
| 03/30/1999 | US5889153 Protein or polypeptide, method for producing the same and intermediate compound therefor |
| 03/30/1999 | US5889152 Therapy for gramnegative bacteria infection in plants and animals |
| 03/30/1999 | US5889151 Genetic engineering; diagnosis kit |
| 03/30/1999 | US5889150 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target protiens |
| 03/30/1999 | US5889149 Purified PDGF AB isoform and method of making it |
| 03/30/1999 | US5889148 Antibiotic peptides |
| 03/30/1999 | US5889147 Bromo-tryptophan conopeptides |
| 03/30/1999 | US5889145 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 03/30/1999 | US5889144 Fused somatotropin epitopic peptides that potentiate growth hormone activity |
| 03/30/1999 | US5889143 Evaluation and treatment of patients with progressive immunosuppression |
| 03/30/1999 | US5888983 Inserting dna, rna into cells to repair genetic disorders |
| 03/30/1999 | US5888977 Therapeutic uses of BPI protein products for human meningococcemia |
| 03/30/1999 | US5888976 Bacillus thuringiensis toxin for pest control |
| 03/30/1999 | US5888974 Genetic engineered polypeptide; blood coagulation |
| 03/30/1999 | US5888973 Administering bactericidal/permeability-increasing protein to treat coronary artery disease |
| 03/30/1999 | US5888970 Technetium-99m labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents |
| 03/30/1999 | US5888969 Crohn*s disease |
| 03/30/1999 | US5888968 Solubilizing agent selected from sodium chloride, isocitrate ions, glutamate, succinate ions, imidazole and sodium dodecyl sulfate; hypertonic; antiinflammatory and anticoagulants |
| 03/30/1999 | US5888965 Method of stimulating bone marrow regeneration |
| 03/30/1999 | US5888963 Treatment of bone disorders with adrenomedullin |
| 03/30/1999 | US5888833 Antigens recognized by antibodies to rheumatoid arthritis, their preparation and their applications |
| 03/30/1999 | US5888818 Dna coding for alpha-or gamma-tubulin which is resistant to herbicides because of non-polar amino acid substitutions; for transgenic cells and plants |
| 03/30/1999 | US5888817 For breast and prostate cancer cells |
| 03/30/1999 | US5888815 Cell cultivation method and medium |
| 03/30/1999 | US5888813 Monoclonal antibodies against human pancreatic islet cells |
| 03/30/1999 | US5888812 Myeloid cell leukemia associated gene MCL-1 |
| 03/30/1999 | US5888811 Isolated nucleic acids; genetic engineering |
| 03/30/1999 | US5888810 Antigenic fusion protein useful for decreasing colonization in chickens |
| 03/30/1999 | US5888809 Hamster EF-1α transcriptional regulatory DNA |
| 03/30/1999 | US5888808 Bacterial polypeptide expression employing tryptophan promoter-operator |
| 03/30/1999 | US5888807 Devices for maintaining and growing human stem and/or hematopoietics cells |
| 03/30/1999 | US5888801 Bacillus thuringiensis |
| 03/30/1999 | US5888799 Recombinant avirulent bacterial antigen delivery system |
| 03/30/1999 | US5888794 Receptor-type phosphotyrosine phosphatase-alpha |
| 03/30/1999 | US5888785 Method for using hydratase or a hydratase-amidase fusion for stereospecifically bioconverting certain racemic nitriles to the corresponding enatiomeric R--or S-amide or s-carboxylic acid |
| 03/30/1999 | US5888780 Using enzymes |
| 03/30/1999 | US5888775 Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof |
| 03/30/1999 | US5888774 Recombinant DNA molecules and expression vectors for erythropoietin |
| 03/30/1999 | US5888772 Amino acid sequences of mutants with higher biological activity; for treatment of anemia and induction of erythropoiesis |
| 03/30/1999 | US5888771 Gene products as targets for the development of antibiotics. |
| 03/30/1999 | US5888770 Spoiiie |
| 03/30/1999 | US5888766 Method for producing recombinant human myoglobin |
| 03/30/1999 | US5888765 Endothelial-cell specific promoter |
| 03/30/1999 | US5888764 Human fas gene promoter region |
| 03/30/1999 | US5888763 Polypeptide |
| 03/30/1999 | US5888762 Neurotropic growth factors comprising a homeobox peptide |
| 03/30/1999 | US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 03/30/1999 | US5888750 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin |
| 03/30/1999 | US5888742 Human phospholipid binding proteins |
| 03/30/1999 | US5888741 Computer-based design and screening of molecules using DNA interactions |
| 03/30/1999 | US5888738 Design of drugs involving receptor-ligand-DNA interactions |
| 03/30/1999 | US5888727 Two vsv gene products have been reported to be present in the nucleus after infection. the two gene products are the newly synthesized 47 nucleotide leader rna and a pre-existing component of infecting virions, a 30 kda protein called the |
| 03/30/1999 | US5888722 Stable cell lines expressing the CFTR protein or a mutant of this protein, tool for selecting molecules having an effect on the intracellular transport of these proteins |
| 03/30/1999 | US5888519 Vaccine |
| 03/30/1999 | US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae |
| 03/30/1999 | US5888516 Genetic engineered protein |
| 03/30/1999 | US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host |
| 03/30/1999 | US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity |
| 03/30/1999 | US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore |
| 03/30/1999 | US5888507 Treatment for insulin dependent diabetes |
| 03/30/1999 | US5888503 Materials and methods for the control of calliphoridae pests |
| 03/30/1999 | US5888502 Recombinant retroviruses |
| 03/30/1999 | US5888498 Cellular and animal models for diseases associated with mitochondrial defects |
| 03/30/1999 | US5888495 Combining macrophage colony stimulating factor, nonionic surfactant, glycine, sucrose, buffer in liquid solution, lyophilizing |
| 03/30/1999 | US5888474 Technetium-99m labeled peptides for GPIIb/IIIa ligands useful for thrombus imaging |
| 03/30/1999 | CA2166707C New stromal cell lines from human bone marrow and their use |
| 03/30/1999 | CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts |
| 03/30/1999 | CA1340473C Method for isolating herpes virus thymidine kinase-encoding dna |
| 03/30/1999 | CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein |
| 03/26/1999 | CA2248390A1 Complex of human growth hormone and zinc and use |
| 03/25/1999 | WO1999014365A1 The porcine adipocyte fatty acid-binding protein encoding gene and methods to localise, identify or mark genes or alleles or quantitative trait loci of farm animals |
| 03/25/1999 | WO1999014357A2 Reagents and methods useful for detecting diseases of the prostate, breast and ovary |
| 03/25/1999 | WO1999014350A1 Rank1, an ankyrin-repeat containing peptide from rice associated with disease resistance |
| 03/25/1999 | WO1999014345A2 Medicament for treating a manifested lyme disease |
| 03/25/1999 | WO1999014344A1 G protein chimeras |
| 03/25/1999 | WO1999014341A2 Proteases from gram-positive organisms |
| 03/25/1999 | WO1999014335A1 Yeast strains for the production of lactic acid |
| 03/25/1999 | WO1999014334A1 Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 03/25/1999 | WO1999014333A2 Improved method of production of pneumococcal surface proteins |
| 03/25/1999 | WO1999014332A1 Plant-origin regulator protein and nucleic acid encoding the same |
| 03/25/1999 | WO1999014331A2 Cyclin-dependent kinase inhibitors and uses thereof |
| 03/25/1999 | WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 03/25/1999 | WO1999014329A1 Human macrophage receptor marco |
| 03/25/1999 | WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/1999 | WO1999014327A2 Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer |
| 03/25/1999 | WO1999014326A1 Mage-3 peptides presented by hla class ii molecules |
| 03/25/1999 | WO1999014325A1 NOVEL Fas LIGAND DERIVATIVE |
| 03/25/1999 | WO1999014324A1 Mammalian genes participating in circadian period |
| 03/25/1999 | WO1999014323A1 Heregulin-gamma |
| 03/25/1999 | WO1999014322A2 Allelic variant of human stat3 |
| 03/25/1999 | WO1999014321A1 Novel therapeutic molecules |
| 03/25/1999 | WO1999014317A1 Methods for the diagnosis of feline infectious anemia |
| 03/25/1999 | WO1999014310A1 Rna export element and methods of use |
| 03/25/1999 | WO1999014244A1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies |
| 03/25/1999 | WO1999014243A1 Immunointeractive molecules and uses therefor |